The FDA confirmed that Janssen had submitted an application for emergency use of its COVID-19 vaccines in the Philippines. The Food and Drug Administration (FDA) on Monday confirmed that Johnson & Johnson’s pharmaceutical arm Janssen had submitted an application for emergency use of its COVID-19 vaccine in the Philippines. According to the Food and Drug … Read more
The supply agreement with Johnson & Johnson was set to be signed this week, according to Galvez. Vaccine czar Secretary Carlito Galvez Jr on Monday said that the supply agreement with Johnson & Johnson was set to be signed this week. During President Rodrigo Duterte’s weekly address on Monday, Galvez gave an update on the … Read more
Johnson & Johnson submitted an emergency use listing to WHO for its COVID-19 vaccine. Johnson & Johnson (J&J) on Friday said that it had submitted an emergency use listing (EUL) to the World Health Organization (WHO) for its COVID-19 vaccine. According to Johnson & Johnson, the process was a prerequisite to supply COVID-19 vaccines to … Read more
J&J CEO reportedly said that annual vaccine shots may be needed for the next several years. The Chief Executive Officer (CEO) of Johnson & Johnson said that annual vaccine shots may be needed for the next several years. Alex Gorsky, the Chief Executive Officer of Johnson & Johnson, on Tuesday told CNBC in an interview … Read more
Johnson & Johnson had requested an EUA for its COVID-19 vaccine in the United States. Johnson & Johnson on Thursday submitted an application for emergency use authorization (EUA) of its COVID-19 vaccine with US health authorities, the company said in a statement. The said process could take several weeks, but the said vaccine would be … Read more
Hancock Tower architect Henry Cobb died at the age of 93. Architect Henry Cobb, an architect who designed the tallest building in New England, died at his home in Manhattan at the age of 93. This, as Pei Cobb Freed & Partners, Henry Cobb’s firm, confirmed about Henry’s passing, saying that he died Monday at … Read more
